Citius Pharmaceuticals
CTXR
CTXR
74 hedge funds and large institutions have $30.4M invested in Citius Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 9 closing their positions.
Holders
74
Holders Change
+19
Holders Change %
+34.55%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
15
Reduced
14
Closed
9
Calls
$721K
Puts
$71K
Net Calls
+$650K
Net Calls Change
+$198K
Top Buyers
1 |
1
BlackRock
New York
|
$9.7M |
2 |
2
State Street
Boston,
Massachusetts
|
$2.53M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$3.13M |
4 |
4
Northern Trust
Chicago,
Illinois
|
$1.23M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$8.02M |